Tuesday 28 February 2017

Global Glucose Monitoring Market with Focus on CGM: Industry Analysis, Growth, Forecast & Outlook 2016-2020

ResearchMoz added Latest Research Report titled " Global Glucose Monitoring Market with Focus on CGM: Industry Analysis & Outlook (2016-2020) " to it's Large Report database.

Glucose Monitoring helps people suffering from diabetes in managing their health and avoiding its associated problems. Any individual can use the results of glucose monitoring to make decisions about food, physical activity, and medications which can help him stay healthy. The most common glucose monitoring solutions are blood glucose meters and continuous glucose monitoring (CGM) systems. In addition to it, the traditional way to check glucose levels involves pricking a fingertip with an automatic piercing device to obtain a blood sample and then using a glucose meter to measure the blood sample's glucose level.

CGM is a way to measure glucose levels in real-time throughout the day and night. CGM systems use a tiny sensor inserted under the skin to check glucose levels in tissue fluid. The sensor stays in place for several days to a week and then must be replaced. It is connected to a transmitter that sends the information via wireless radio frequency to a monitoring and display device. The device can detect and notify you if glucose is reaching a high or low limit.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=759406

The key factors which are anticipated to drive glucose monitoring market include growing number of diabetic patients, increase in ageing population, rising obese population, growing urban population, increase in healthcare expenditure and desk bound lifestyle. Some of the significant developments of this industry include introduction of new innovative products in the market, approval of artificial pancreas, increasing awareness about health and glucose monitoring, growing investment in digital health solutions and increase in CGM recommendations. However, the challenge to be faced ahead is CGM reimbursement, extreme competition among companies and legal regulations.

This report offers a comprehensive analysis of the Global Glucose Monitoring market with focus on CGM. Furthermore, market dynamics such as key trends and development; and challenges are analyzed in depth. On the contention front, the global market is reined by few major players namely Abbott Laboratories, Medtronic, and DexCom. The competitive landscape of the respective market, along with the company profiles of the leading players are also discussed in detail.

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

Table of Content

1. Glucose Monitoring: An Introduction
1.1 Diabetes   
1.1.1 Types of Diabetes   
1.1.2 Symptoms    of Diabetes   
1.1.3 Diabetes Risk Factors   
1.2 Blood Glucose Monitoring   
1.2.1 Blood Glucose Meter   
1.2.2 Types of Blood Glucose Meters   
1.3 Self-Monitoring Blood Glucose   
1.4 Continuous Glucose Monitor (CGM)

2. Market Analysis
2.1 Global Diabetes Devices Market by Segment
2.2 Global Glucose Monitoring Market by Value   
2.2.1 Traditional Glucose Monitoring Market   
2.2.2 Global Continuous Glucose Monitoring Market by Value

3. The US CGM Market
3.1 The US Diabetes Population   
3.2 The US Diagnosed Diabetes Population   
3.3 The US Type 1 Diabetes Population   
3.4 The US Type 2 Diabetes Population   
3.5 CGM Diabetes Type-1 Penetration in the US
3.6 CGM Diabetes Type-1 Patient Volume in the US   
3.7 CGM Diabetes Type-1 Patient Volume in the US by Category
3.8 CGM Diabetes Type-1 Growth in the US by Volume   
3.9 CGM Diabetes Type-1 Revenue Growth in the US

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global Drug Device Combination Products Market to grow at a CAGR of 11.95% during 2015-2019: Key Vendors are Medtronic, Boston Scientific, Roche Diagnostics, Abbott Laboratories

ResearchMoz added Latest Research Report titled " Global Drug Device Combination Products Market 2015-2019 " to it's Large Report database.

About Drug Device Combination Products
Drug device combination products consist of two regulated components: an active pharmaceutical ingredient and a medical device. These two standardized components are combined, either chemically or physically for developing one component. The drugs present in the device are either impregnated or surface coated. The drug device combination products are considered to be highly innovative in the area of advanced healthcare such as biomedical nanotechnology and development of regenerative medicine.

Technavio's analysts forecast the global drug device combination products market to grow at a CAGR of 11.95% over the period 2014-2019.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=459100

Covered in this report
The report includes the present scenario and the growth prospects of the global drug device combination products market for 2015-2019. The market can be segmented by product type:
Drug eluting stent
Prefilled syringes
Wearable injectors
Insulin delivery systems

Technavio's report, Global Drug Device Combination Products Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, APAC, and EMEA; it also covers the landscape of the global drug device combination products market and its growth prospects in the coming years. The report includes a discussion of the key vendors operating in this market.

Read All Oncology Market Research Reports @ http://www.researchmoz.us/oncology-market-reports-108.html

Table of Content

PART 01: Executive summary
Highlights
PART 02: Scope of the report
Market overview
Offerings of the top vendors
PART 03: Market research methodology
Research methodology
Economic indicators
PART 04: Introduction
Key market highlights
PART 05: Market landscape
Market overview
Market size and forecast
Five forces analysis
PART 06: Market segmentation by product
Drug-eluting stents
Prefilled syringes
Wearable injectors
Insulin delivery systems
PART 07: Geographical segmentation
Global drug device combination products market by geographical segmentation
Drug device combination products market in Americas
Drug device combination products market in EMEA
Drug device combination products market in APAC
PART 08: Market drivers
PART 09: Impact of drivers
PART 10: Market challenges

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global and China Vitamin B Industry 2014 Market Research Report Emerging Trends, Growth Drivers, Future Outlook and Opportunities

ResearchMoz added Latest Research Report titled " Global and China Vitamin B Industry 2014 Market Research Report " to it's Large Report database.

The report firstly introduced Vitamin B basic information included Vitamin B definition Vitamin Bssification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Military Infrared (EO/IR) Systemss industry policy and plan, Vitamin B product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Military Infrared (EO/IR) Systemss capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Vitamin B products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed Global and China Vitamin B capacity production capacity market share production market share supply demand shortage import export consumption etc data statistics, and then introduced Global and China Vitamin B 2009-2019 capacity production price cost profit production value gross margin etc information.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=220737

And also listed Military Infrared (EO/IR) Systemss upstream raw materials equipments and down stream clients survey analysis and Military Infrared (EO/IR) Systemss marketing channels industry development trend and proposals. In the end, The report introduced Military Infrared (EO/IR) Systemss new project SWOT analysis Investment feasibility analysis investment return analysis and also give related research conclusions and development trend analysis on Global and China Military Infrared (EO/IR) Systemss industry.

In a word, it was a depth research report on Global and China Military Infrared (EO/IR) Systemss industry. And thanks to the support and assistance from Vitamin B industry chain related technical experts and marketing engineers during Research Team survey and interviews.

Table of Content

Chapter One Vitamin B Industry Overview
1.1 Vitamin B Definition
1.2 Vitamin B Vitamin Bssification and Application
1.3 Vitamin B Industry Chain Structure
1.4 Vitamin B Industry Overview

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Chapter Two Vitamin B International and China Market Analysis
2.1 Vitamin B Industry International Market Analysis
2.1.1 Vitamin B International Market Development History
2.1.2 Vitamin B Product and Technology Developments
2.1.3 Vitamin B Competitive Landscape Analysis
2.1.4 Vitamin B International Key Countries Development Status
2.1.5 Vitamin B International Market Development Trend
2.2 Vitamin B Industry China Market Analysis
2.2.1 Vitamin B China Market Development History
2.2.2 Vitamin B Product and Technology Developments
2.2.3 Vitamin B Competitive Landscape Analysis
2.2.4 Vitamin B China Key Regions Development Status
2.2.5 Vitamin B China Market Development Trend
2.3 Vitamin B International and China Market Comparison Analysis

Chapter Three Vitamin B Development Environmental Analysis
3.1 China Macroeconomic Environment Analysis
3.1.1 China GDP Analysis
3.1.2 China CPI Analysis
3.2 European Economic Environmental Analysis
3.3 United States Economic Environmental Analysis
3.4 Japan Economic Environmental Analysis
3.5 Other Regions Economic Environmental Analysis
3.6 Global Economic Environmental Analysis

Chapter Four Vitamin B Development Policy and Plan
4.1 Vitamin B Industry Policy Analysis
4.2 Vitamin B Industry News Analysis
4.3 Vitamin B Industry Development Trend

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Public Hospitals Market in Poland 2014 Investment Plans and Comparative Analysis by Voivodship

ResearchMoz added Latest Research Report titled " Public Hospitals Market in Poland 2014 Investment Plans and Comparative Analysis by Voivodship " to it's Large Report database.

What are the plans for investment in Poland’s Public Hospitals Market?
Report provides comparative analysis by voivodship and growth prospects in coming years.

How many public hospitals are currently operating in Poland? What is the total number of beds provided? Which are planning investments? Which are planning to add new specialisations? What is the value of the contract with the National Health Fund (NFZ) of each of them? Which upcoming regulatory changes will affect investment in public hospitals in Poland?

Healthcare and business professionals who are searching for answers to these important questions can find them in Public hospitals market in Poland 2014, Investment plans and comparative analysis by voivodship. This valuable publication digs deep into the current market situation, providing current snapshots of the largest market participants as well as in-depth evaluation of their plans for expansion in the years ahead. This exceptional reference tool also reveals the levels of market saturation in various areas.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=221291

It offers readers convenient access to a collection of 600+ database records, useful in performing comparative analyses of the facilities, services and medical specialisations (including the number of bed for each specialisation) available in Poland. This tool is presented in easy to access Excel format. It is a timesaving resource for performing competition and saturation analysis in regions across Poland.

The report also delivers the total number of public hospitals on the market, those planning transformations to the private sector. It examines financing choices and National Health Fund contracts, along with specific investments in the public hospitals segment planned for the coming years.

In addition, this unique document presents detailed profiles of the largest hospitals and expected regulatory changes and legal modifications that can potentially impact growth and overall market development. It offers the informative results of a recent survey of market participants that featured queries about current market conditions, prospects for growth and available opportunities for businesses considering market entry in the near future.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Table of Content

1. Methodology 7

2. Executive summary 14

3. Overview of the public hospitals market in Poland 17

4. Growth prospects for the public hospitals sector in Poland 2014-2018 38

5. Results of the survey conducted among public hospitals in Poland 58

6. Overview and assessment of the growth potential for the most attractive specialisations 73

7. Profiles of selected public hospitals in Poland 106

8. Overview of public hospitals in individual voivodships  135

9. Analysis of saturation with inpatient services in public hospitals in the major cities in Poland 171

10. List of graphs 187

11. List of tables 190

12. About PMR 195

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global and China Single Vitamins Industry 2014 Market Research Report Analysis, Applications, Demands and Growth Forecast

ResearchMoz added Latest Research Report titled " Global and China Single Vitamins Industry 2014 Market Research Report " to it's Large Report database.

The report firstly introduced Single Vitamins basic information included Single Vitamins definition Single Vitaminsssification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Military Infrared (EO/IR) Systemss industry policy and plan, Single Vitamins product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Military Infrared (EO/IR) Systemss capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Single Vitamins products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed Global and China Single Vitamins capacity production capacity market share production market share supply demand shortage import export consumption etc data statistics, and then introduced Global and China Single Vitamins 2009-2019 capacity production price cost profit production value gross margin etc information.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=221533

And also listed Military Infrared (EO/IR) Systemss upstream raw materials equipments and down stream clients survey analysis and Military Infrared (EO/IR) Systemss marketing channels industry development trend and proposals. In the end, The report introduced Military Infrared (EO/IR) Systemss new project SWOT analysis Investment feasibility analysis investment return analysis and also give related research conclusions and development trend analysis on Global and China Military Infrared (EO/IR) Systemss industry.

In a word, it was a depth research report on Global and China Military Infrared (EO/IR) Systemss industry. And thanks to the support and assistance from Single Vitamins industry chain related technical experts and marketing engineers during Research Team survey and interviews.

Table of Content

Chapter One Single Vitamins Industry Overview
1.1 Single Vitamins Definition
1.2 Single Vitamins Single Vitaminsssification and Application
1.3 Single Vitamins Industry Chain Structure
1.4 Single Vitamins Industry Overview

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Chapter Two Single Vitamins International and China Market Analysis
2.1 Single Vitamins Industry International Market Analysis
2.1.1 Single Vitamins International Market Development History
2.1.2 Single Vitamins Product and Technology Developments
2.1.3 Single Vitamins Competitive Landscape Analysis
2.1.4 Single Vitamins International Key Countries Development Status
2.1.5 Single Vitamins International Market Development Trend
2.2 Single Vitamins Industry China Market Analysis
2.2.1 Single Vitamins China Market Development History
2.2.2 Single Vitamins Product and Technology Developments
2.2.3 Single Vitamins Competitive Landscape Analysis
2.2.4 Single Vitamins China Key Regions Development Status
2.2.5 Single Vitamins China Market Development Trend
2.3 Single Vitamins International and China Market Comparison Analysis

Chapter Three Single Vitamins Development Environmental Analysis
3.1 China Macroeconomic Environment Analysis
3.1.1 China GDP Analysis
3.1.2 China CPI Analysis
3.2 European Economic Environmental Analysis
3.3 United States Economic Environmental Analysis
3.4 Japan Economic Environmental Analysis
3.5 Other Regions Economic Environmental Analysis
3.6 Global Economic Environmental Analysis

Chapter Four Single Vitamins Development Policy and Plan
4.1 Single Vitamins Industry Policy Analysis
4.2 Single Vitamins Industry News Analysis
4.3 Single Vitamins Industry Development Trend

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global and China Heart Health Food and Drinks Industry 2014 Market Research Report Growth Prospacts, Business Overview and Analysis

ResearchMoz added Latest Research Report titled " Global and China Heart Health Food and Drinks Industry 2014 Market Research Report " to it's Large Report database.

The report firstly introduced Heart Health Food and Drinks basic information included Heart Health Food and Drinks definition Heart Health Food and Drinksssification application industry chain structure industry overview; international market analysis, China domestic market analysis, Macroeconomic environment and economic situation analysis and influence, Military Infrared (EO/IR) Systemss industry policy and plan, Heart Health Food and Drinks product specification, manufacturing process, product cost structure etc. then statistics Global and China key manufacturers Military Infrared (EO/IR) Systemss capacity production cost price profit production value gross margin etc details information, at the same time, statistics these manufacturers Heart Health Food and Drinks products customers application capacity market position company contact information etc company related information, then collect all these manufacturers data and listed Global and China Heart Health Food and Drinks capacity production capacity market share production market share supply demand shortage import export consumption etc data statistics, and then introduced Global and China Heart Health Food and Drinks 2009-2019 capacity production price cost profit production value gross margin etc information.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=222427

And also listed Military Infrared (EO/IR) Systemss upstream raw materials equipments and down stream clients survey analysis and Military Infrared (EO/IR) Systemss marketing channels industry development trend and proposals. In the end, The report introduced Military Infrared (EO/IR) Systemss new project SWOT analysis Investment feasibility analysis investment return analysis and also give related research conclusions and development trend analysis on Global and China Military Infrared (EO/IR) Systemss industry.

In a word, it was a depth research report on Global and China Military Infrared (EO/IR) Systemss industry. And thanks to the support and assistance from Heart Health Food and Drinks industry chain related technical experts and marketing engineers during Research Team survey and interviews.

Table of Content

Chapter One Heart Health Food and Drinks Industry Overview
1.1 Heart Health Food and Drinks Definition
1.2 Heart Health Food and Drinks Heart Health Food and Drinksssification and Application
1.3 Heart Health Food and Drinks Industry Chain Structure
1.4 Heart Health Food and Drinks Industry Overview

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Chapter Two Heart Health Food and Drinks International and China Market Analysis
2.1 Heart Health Food and Drinks Industry International Market Analysis
2.1.1 Heart Health Food and Drinks International Market Development History
2.1.2 Heart Health Food and Drinks Product and Technology Developments
2.1.3 Heart Health Food and Drinks Competitive Landscape Analysis
2.1.4 Heart Health Food and Drinks International Key Countries Development Status
2.1.5 Heart Health Food and Drinks International Market Development Trend
2.2 Heart Health Food and Drinks Industry China Market Analysis
2.2.1 Heart Health Food and Drinks China Market Development History
2.2.2 Heart Health Food and Drinks Product and Technology Developments
2.2.3 Heart Health Food and Drinks Competitive Landscape Analysis
2.2.4 Heart Health Food and Drinks China Key Regions Development Status
2.2.5 Heart Health Food and Drinks China Market Development Trend
2.3 Heart Health Food and Drinks International and China Market Comparison Analysis

Chapter Three Heart Health Food and Drinks Development Environmental Analysis
3.1 China Macroeconomic Environment Analysis
3.1.1 China GDP Analysis
3.1.2 China CPI Analysis
3.2 European Economic Environmental Analysis
3.3 United States Economic Environmental Analysis
3.4 Japan Economic Environmental Analysis

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Lip Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends, Forecast and Opportunities 2014 - 2020

ResearchMoz added Latest Research Report titled " Lip Cancer Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020 " to it's Large Report database.

Lip Cancer is a type of oral cancer that begins in the squamous cells, lining the lips and the oral cavity. Symptoms of lip cancer include soreness, lumps or pale colored ulcers in the mouth that are usually painless at first but may become painful with disease progression. On early diagnosis, this type of cancer can be cured either by surgery and/or radiation therapy. In cases of advanced stages, chemotherapy and targeted therapies may also be used. Emergency treatment is recommended in cases where cancer has spread and is known to interfere with the function of a vital organ. Factors associated with the occurrence of lip cancer include smoking, alcohol consumption, bad oral hygiene, poor diet, and infection by human papillomavirus (HPV) as well as cases of immune-suppression. Men are at a greater risk than women in occurrence of lip cancer particularly above 45 years of age. Prognosis of lip cancer depends on the stage of the cancer, exact location, and the extent of its spread.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=222451

The global lip cancer market can be segmented based on pipeline assessment, treatment, diagnosis and geography. Pipeline assessment includes analysis by phase of clinical development of drugs.  Diagnostic tests involve physical examination for sores, lumps or mouth ulcers. Biopsy as well as X-rays and CT scans may also be done to determine the spread of the cancer. Other diagnostic tests include endoscopy, exfoliative cytology, Magnetic Resonance Imaging (MRI), barium swallow, PET scan and bone scan. Treatment of lip cancer depends upon the cancer stage, size, location of the tumor and patient’s general health. Surgery is usually recommended to remove the tumor if it is small enough. The surgery may include wide local excisions, neck dissection and plastic surgery. Wide local excision involves removal of the bone and also some of the healthy tissue near the cancerous tumor. Neck dissection is the removal of lymph nodes and is generally done when the cancer has spread from the lip and oral cavity.  In case of larger tumors, surgery is combined with radiation and chemotherapy. The most commonly used chemotherapy drugs for this type of cancer are cisplatin and 5-fluorouracil while other drugs include carboplatin, bleomycin, methotrexate and docetaxel. Other treatments are speech therapy or therapies to improve movement, swallowing, and chewing. However there are certain drawbacks associated with the radiation therapy such as difficulty in swallowing and dry mouth.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Regular use of photo protective lip products reduces the risk of lip cancer since they help reduce exposure to U.V. radiation. However a number of commercially available photo protective lip blocks may be poorly absorbed and can be disrupted easily by UV radiation, losing effectiveness. Extensive clinical research is being carried for use of chemotherapy drugs in combination such as paclitaxel and gemcitabine. Other new treatment options tested in the clinical trials are hyper fractionated radiation therapy and hyperthermia therapy.

Geographically, the lip cancer market can be categorized into four major regions namely North America, Europe, Asia Pacific and Rest of the World. Lip cancer comprises approximately 0.6% of all the cancers in the U.S. Although Asia-Pacific may have considerable number of lip cancer cases, these incidences may not be diagnosed due to low awareness and errors. North America is the largest regional market for the cancer drugs followed by the developing countries such as India and China. Growing penetration of generic drugs is expected to have a major impact on the patented cancer drugs. Some of the key players contributing to the global lip cancer market are Astra Zeneca plc, Bristol Myers Squibb, Celgene, Eli Lilly & Co., Hofmann La Roche, Pfizer, Sanofi Aventis, Teva Pharmaceuticals, and Novartis AG.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
Market growth drivers
  •     Factors limiting market growth
  •     Current market trends
  •     Market structure
  •     Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Premenstrual Dysphoric Disorder Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

ResearchMoz added Latest Research Report titled " Premenstrual Dysphoric Disorder Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020 " to it's Large Report database.

Premenstrual Dysphoric Disorder
(PMDD) is a severe condition in which most women develop depression, irritability and tension before menstruation. The U.S. Department of Health and Human Services stated that, premenstrual dysphoric disorder is more severe and serious compared to premenstrual syndrome (PMS). Exact cause for premenstrual dysphoric disorder is unknown however researchers demonstrated that few factors are associated with it that includes depression, vitamin deficiency, changes in hormone related to menstrual cycle, drinking alcohol and eating salty food. Possible signs and symptoms for premenstrual dysphoric disorder includes feeling sadness or hopelessness, fatigue or low energy, food cravings, panic attacks and change in appetite. Other symptoms of premenstrual dysphoric disorder can be sleep problems, difficulty in concentration and physical problems such as bloating, breast tenderness, swelling, headaches, joint or muscle pain.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=222453

Women with unhygienic lifestyle are at high risk for developing premenstrual dysphoric disorder. Currently no diagnosis test is available in the market for detection of premenstrual dysphoric disorder but sometimes psychiatric evaluation might be performed to rule out the other conditions associated with premenstrual dysphoric disorder. Treatment and management of premenstrual dysphoric disorder includes good nutrition, exercise and medication (Sarafem, Paxil CR, and Zoloft).

Increasing unhygienic lifestyle among women is considered as a major market driving factor for the global premenstrual dysphoric disorder treatment market because premenstrual dysphoric disorder is mostly seen among women with unhygienic lifestyle. Moreover, growing knowledge among women about premenstrual dysphoric disorder would further accentuate the market growth in few developing nations in the world. In addition, treatment products for premenstrual dysphoric disorder is easily available in almost all medical stores across the world are considered as a market driving factor for this market. However, lack of diagnostic tests available in the market for detection of premenstrual dysphoric disorder would restrict its demand in the global premenstrual dysphoric disorder treatment market.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

The U.S. National Library of Medicine stated that, premenstrual dysphoric disorder affects 3% to 8% of the U.S. women before they are having menstrual periods. Hence, North America and Europe dominates the global market for premenstrual dysphoric disorder treatment due to high prevalence rate of premenstrual dysphoric disorder in these regions. Moreover, favorable initiative taken by the federal government would also account for the market growth of the North American and European premenstrual dysphoric disorder market. In addition, strong demand of treatment product of premenstrual dysphoric disorder in North American and European regions is also accounted for the market growth in these regions. Asia-Pacific is considered as an untapped market due to lack of awareness among people in few of the remote areas in Asian countries. Asian market growth will be fuelled by the presence of untapped opportunities due to extensive increase in healthcare infrastructure (healthcare cost, healthcare facility and healthcare budget). Rest of the world (RoW) holds fourth position in the global premenstrual dysphoric disorder treatment market due to poor economic and health condition in most of the African countries. 

Some of the major market players involved in manufacturing the treatment product of premenstrual dysphoric disorder and contributing the global market share includes Eli Lilly and Company, Endo Pharmaceuticals, Forest Laboratories, Johnson & Johnson, Pfizer, Inc., GlaxoSmithKline plc, Abbott Healthcare, Merck and Co., Cipla Laboratories, Novartis AG, Bristol Meyer Squibb, Dr. Reddy’s Laboratories Ltd. among others.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. This report provides comprehensive analysis of
  •     Market growth drivers
  •     Factors limiting market growth
  •     Current market trends
  •     Market structure
  •     Market projections for upcoming years
This report is a complete study of current trends in the market, industry growth drivers, and restraints. It provides market projections for the coming years. It includes analysis of recent developments in technology, Porter’s five force model analysis and detailed profiles of top industry players. The report also includes a review of micro and macro factors essential for the existing market players and new entrants along with detailed value chain analysis.

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Osteoporosis Therapeutics in Asia-Pacific Markets will be valued at $7.7 billion in 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies

ResearchMoz added Latest Research Report titled " Osteoporosis Therapeutics in Asia-Pacific Markets to 2022 - Growth Driven by Rising Prevalence, Growing Awareness and Expected Launch of Anabolic Therapies " to it's Large Report database.

Osteoporosis, the most common metabolic bone disease, is characterized by low bone mass, microarchitectural deterioration of bone tissue, and a consequent increase in fracture risk. Osteoporosis is generally known as an asymptomatic disease, as there are no visible signs until a fracture occur. In most of the cases, fracture is the clinical outcome associated with osteoporosis, and it has a complex pathogenesis that involves trauma to the bone and increased skeletal fragility. Osteoporosis is a major global public health problem, associated with significant morbidity, mortality, and socioeconomic burden. An aging global population will result in an increased number of people living with the condition, thereby acting as a driver for revenue growth.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=784620

The osteoporosis market is undergoing a gradual transition from a focus on antiresorptive therapies to anabolic drug treatment. The market is set to be driven by recently launched products, and the approval of drugs that will supplement current market leaders and offer greater therapeutic options. The marketed products landscape comprises a wide range of treatment options, including bisphosphonates, SERMs, RANKL inhibitors, a dual-action non-bisphosphonate (strontium ranelate), calcitonins and PTH analogues. Nevertheless, significant unmet need remains for products that can improve bone formation, as well as effective antiresorptive therapies that offer increased compliance with few side effects.

Scope
  • The osteoporosis Asia-Pacific market will be valued at $7.7 billion in 2022, growing from $4.5 billion in 2015 at a CAGR of 7.8%.
  • Bisphosphonates and SERMs dominate the osteoporosis market. However, unmet needs exist in terms of safety and efficacy. Will the drugs under development fulfill the unmet needs of the osteoporosis market?
  • How will immunotherapies such as Prolia contribute to growth?
  • What effect will the patent expirations of currently branded therapies have on market value?
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

1 Table of Contents
1 Table of Contents 5
1.1 List of Tables 8
1.2 List of Figures 8

2 Introduction 10
2.1 Disease Introduction 11
2.2 Epidemiology 11
2.3 Symptoms 12
2.4 Etiology and Pathophysiology 14
2.4.1 Pathophysiology 14
2.5 Diagnosis 15
2.6 Disease Stages 17
2.7 Prognosis 20
2.8 Treatment Options 21
2.8.1 Treatment Algorithm 21
2.8.2 Pharmacological Treatments 22
2.8.3 Non-Pharmacological Treatments 24
2.8.4 Exercise 24
2.8.5 Dietary Interventions 24

3 Marketed Products 26
3.1 Overview 26
3.2 Bisphosphonates 26
3.2.1 Risedronate - Warner Chilcott 26
3.2.2 Alendronate - Merck & Co 28
3.2.3 Boniva (ibandronate) - Roche 29

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global Ophthalmology Drugs Market to 2022 - Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period

ResearchMoz added Latest Research Report titled " Global Ophthalmology Drugs Market to 2022-Angiogenesis Modulators and Gene Therapies to Boost Overall Revenue within the Forecast Period " to it's Large Report database.

Ophthalmology is a therapy area that deals with the diagnosis, treatment and prevention of diseases associated with the eyes and visual system. Most eye disorders occur over a long period of time, and are initially asymptomatic or cause only a slight decrease in vision. However, over time this becomes quite marked. Ophthalmologic disorders cannot currently be cured, and treatment is aimed at managing the disease indication in order to reduce the severity of symptoms and slow progression.

Angiogenesis inhibitors are the most effective and most common therapies used in ophthalmology; this class of compounds has been the most commercially successful in the past decade, with products such as Eylea and Lucentis generating strong annual revenues. Although there are many generics available across the majority of ophthalmology disorders, there are a number of premium products that attract substantial revenues – in particular Eylea, Lucentis, Lumigan and Restasis. The report focuses on five key indications within ophthalmology: glaucoma, age-related macular degeneration (AMD), diabetic macular edema, diabetic retinopathy and dry eye syndrome. There are currently no therapeutic options available for the treatment of dry AMD, increasing the need for extensive R&D within this area. 

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=799448

Although there is a high degree of failure and uncertainty within the R&D of ophthalmology drugs, the number of drugs in the pipeline is very high, at 734. The majority of pipeline products are novel active pharmaceutical ingredients, with only a small proportion of products being either generics or repositioned from other indications.  This shows progression in terms of the variety of different molecules being developed as therapeutic agents within the ophthalmology pipeline. The expected growth of the ophthalmology market over the forecast period is attributed to the approval of new drugs, as well as rising prevalence.

Scope
  • Global revenues for the ophthalmology market are forecast to grow at a compound annual growth rate of 9.48%, from $13.7 billion in 2015 to $26 billion in 2022. Which drugs will achieve blockbuster status and how will the key player companies perform during the forecast period?
  • The ophthalmology pipeline is large and diverse, and contains 734 products. How does the composition of the pipeline compare with that of the existing market?
  • What mechanisms of action and molecule types are most commonly being trialed in pipeline products in the various key indications?
  • Which products will contribute to market growth most significantly, and which will achieve blockbuster status?
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 9
2.1 Therapy Area Introduction 9
2.1.1 Glaucoma 9
2.1.2 Age-Related Macular Degeneration 9
2.1.3 Diabetic Macular Edema 10
2.1.4 Diabetic Retinopathy 10
2.1.5 Dry Eye Syndrome 10
2.2 Symptoms 11
2.3 Etiology and Pathophysiology 13
2.3.1 Etiology 13
2.3.2 Pathophysiology 15
2.4 Co-morbidities and Complications 18
2.5 Epidemiology Patterns; Prevalence, Patient Segmentation, and Diagnostic and Treatment Usage Rates 19
2.5.1 Glaucoma 19
2.5.2 Age-Related Macular Degeneration 20
2.5.3 Diabetic Macular Edema 22
2.5.4 Diabetic Retinopathy 22
2.5.5 Dry Eye Syndrome 24
2.6 Treatment 26

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

ResearchMoz added Latest Research Report titled " Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation " to it's Large Report database.

Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable auto-immune disease that affects the joints, and is characterized by synovial inflammation and hyperplasia. It occurs when a number of aberrant cell signaling events trigger chronic inflammation of the synovium – the soft tissue of the joint – leading to pain, joint stiffness, and eventually deformity and disability.

With the disease affecting 0.3–1.0% of the global population, the societal and economic costs of RA are substantial. The large target patient population and the relatively high annual cost of therapy have resulted in a crowded, highly lucrative market.

Treatment options have improved and diversified substantially over the past two decades, largely owing to the advent of biologics. Despite this, considerable unmet needs remain within RA. Consequently, opportunities for future drug developments remain significant, particularly for first-in-class innovation, which is the area most likely to produce substantial clinical advances.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=799450

Scope
  • Treatment options for RA have advanced over the past two decades, resulting in a crowded, competitive market landscape.
  • What is the pathophysiology of RA?
  • Which products and therapeutic strategies dominate the clinical and commercial landscapes?
  • What are the most significant unmet needs within the RA market?
  • Considerable diversification from current market trends is evident within the RA pipeline.
  • Which molecular targets are most prominent within the pipeline?
  • What proportion of pipeline products are first in class?
  • Which first-in-class targets are most promising?
  • Deal values for licensing and co-development deals vary considerably.
  • How many strategic consolidations have been completed in the past decade?
  • Which types of assets attract the largest deal values?
  • Which first-in-class pipeline products have no prior involvement in licensing or co-development deals?
Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

1 Table of Contents 2
1.1 List of Tables 3
1.2 List of Figures 3

2 Executive Summary 5
2.1 A Crowded, Competitive Market, with Significant Unmet Needs Remaining 5
2.2 Early-Stage Pipeline Offers Greatest Promise for First-in-Class Innovation 5
2.3 Cytokine and Cytokine Receptors, as well as Protein Kinases, Largely Dominate First-in-Class Pipeline Products 5

3 The Case for Innovation 6
3.1 Growing Opportunities for Biologic Products 7
3.2 Diversification of Molecular Targets 7
3.3 Innovative First-in-Class Development Remains Attractive 8
3.4 Regulatory and Reimbursement Policy Shifts Favor First-in-Class Product Innovation 8
3.5 Sustained Innovation 9
3.6 GBI Research Report Guidance 9

4 Clinical and Commercial Landscape 10
4.1 Disease Overview 10
4.2 Disease Symptoms 10
4.3 Epidemiology 11
4.4 Etiology 11
4.5 Pathophysiology 11
4.6 Co-morbidities and Complications 12
4.7 Diagnosis 12
4.7.1 Blood Tests 12
4.7.2 1987 Rheumatoid Arthritis Classification 13

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global Diabetes and Obesity Drugs Market $163 Billion to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment

ResearchMoz added Latest Research Report titled " Global Diabetes and Obesity Drugs Market to 2022 - Insulins and GPCRs Retain Commercial Prominence, While High Unmet Need Remains in Weight Loss Treatment " to it's Large Report database.

Diabetes is a chronic metabolic disease characterized by hyperglycemia (high blood glucose levels) that results from defects in insulin secretion, insulin action, or both. Chronic hyperglycemia in diabetic patients is associated with long-term damage, dysfunction and failure of multiple organs, including the eyes, kidneys, nerves, heart and blood vessels. The vast majority of diabetes mellitus patients can be classified as having either type 1 diabetes mellitus (T1DM) or type 2 diabetes mellitus (T2DM). Obesity, meanwhile, is defined as abnormal or excessive body fat accumulation that presents a risk to health.

A current global rise in T2DM prevalence is intrinsically linked with the current global rise in obesity. The rapidly increasing global obesity prevalence has resulted in it being considered a global epidemic, and there is a vast and growing global patient population potentially requiring pharmacotherapeutic treatment.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=799451

Historically anti-obesity therapeutics have been out of favor due to safety concerns. Both diabetes and obesity products are commonly associated with cardiovascular adverse events, and this is further compounded by concerns relating to cancer development through long-term usage of anti-obesity products. This has resulted in an unmet need for products with favorable safety and efficacy profiles, particularly in the case of obesity.

The market size for the diabetes and obesity disease cluster is set to increase considerably, driven by the success of a number of T2DM pipeline products, and a rapidly expanding global patient population. However, obesity pipeline activity is set to remain markedly low, despite a patient population of epidemic proportions.

Read All Pharmaceutical Market Research Reports @ http://www.researchmoz.us/pharmaceutical-market-reports-38.html

Table of Contents

1 Table of Contents 4
1.1 List of Tables 6
1.2 List of Figures 6

2 Introduction 9
2.1 Therapy Area Introduction 9
2.1.1 Diabetes 9
2.1.2 Obesity 10
2.2 Symptoms 11
2.2.1 Diabetes 11
2.2.2 Obesity 11
2.3 Etiology and Pathophysiology 11
2.3.1 Type 1 Diabetes Mellitus 11
2.3.2 Type 2 Diabetes Mellitus 12
2.3.3 Obesity 12
2.3.4 The Association between Obesity and T2DM 13
2.4 Comorbidities and Complications 13
2.5 Epidemiology Patterns and Forecasts across the 7MM 14
2.5.1 Diabetes 15
2.5.2 Obesity 16
2.6 Treatment 17
2.6.1 Diabetic Pharmacotherapeutics 17
2.6.2 Insulin Therapy 18
2.6.3 Amylin Analogs 19
2.6.4 Obesity Pharmacotherapeutics 20

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global Self-Care Medical Devices Market to Grow at CAGR of 7.0% from 2013 to 2019 due Increasing Prevalence of Diseases

ResearchMoz added Latest Research Report titled " Self-Care Medical Devices Market (Blood Pressure Monitors, Heart Rate Monitors, Body Temperature Monitors, Blood Glucose Monitors, Pregnancy/Fertility Test Kits, Pedometers, Sleep Apnea Monitors and Nebulizers) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast (Value and Volume),2013 - 2019 " to it's Large Report database.

Self-care Medical Devices are those devices that are used for measuring and monitoring various vital parameters of a patient. These devices play an important role in monitoring blood sugar level, heart rate, hypertension and other conditions. With increasing healthcare awareness, the demand for self-care medical devices is also expected to increase during the forecast period. The market for self-care medical devices is segmented as blood glucose monitors, blood pressure monitors, temperature monitors, holter monitors, pregnancy/fertility test kits, sleep apnea monitors, nebulizers and pedometers. This report also explains various technological advancements taking place in each segment. The report includes market estimations of the global self-care medical devices market in terms of value (USD million) for the period 2013 – 2019, considering 2012 as the base year. In addition, current market trends and recent developments are taken into consideration while determining the growth rate of the global self-care medical devices market. The report provides market size and forecasts for each segment and geographic region with CAGR % for the period from 2013 to 2019.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=182440

The market is also forecasted in terms of value (USD million) for the period 2013 – 2019 for four major geographic regions, namely North America, Europe, Asia-Pacific and Rest of the World (RoW). A detailed qualitative analysis of the factors responsible for driving and restraining the growth of the self-care medical devices market and future opportunities are provided in the report. A PESTLE analysis has also been done while estimating individual geographies in order to provide current as well as future status. A list of recommendations for existing as well as new entrants has been discussed in the study which would help in decision making.

Some of the key market players of the global self-care medical devices market include 3M Healthcare, Abbott Laboratories, GE Healthcare, Medtronic, Inc., Johnson and Johnson, Philips Healthcare and others. Market players are profiled in this report on the basis of attributes such as company overview, financial overview, business strategies adopted by the companies to ensure sustainability and maximize profits, product portfolio and recent developments.

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

Table of Content

Chapter 1 Preface
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology
1.3.1 Sources
1.3.1.1 Secondary Research
1.3.1.2 Primary Research
1.3.1.3 Models
1.3.1.4 Assumptions

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Self-Care Medical Devices Market (2012 & 2019)
2.2 Global Self-Care Medical Devices Market, by Segments, 2012 (USD Million)

Chapter 3 Market Overview
3.1 Overview
3.2 Market Drivers
3.2.1 Rising prevalence of chronic and lifestyle diseases
3.2.2 Technological advancements
3.2.3 Changing demographics
3.2.4 Increasing preference for remote patient monitoring
3.3 Market Restraints
3.3.1 Inaccuracy in measurement may lead to fatal health disorders and also misguide treatment therapy
3.4 Opportunities
3.4.1 Investing in emerging economies
3.5 Porter’s Five Forces Analysis: Global Self-Care Medical Devices Market
3.5.1 Bargaining Power of Buyers - High
3.5.2 Bargaining Power of Suppliers - Medium
3.5.3 Threat of New Entrants - Low

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Global Nanomedicine Market: Increased Research Collaborations to Drive Market in Asia Pacific at 14.6% CAGR, 2013 - 2019

ResearchMoz added Latest Research Report titled " Nanomedicine Market (Neurology, Cardiovascular, Anti-inflammatory, Anti-infective, and Oncology Applications) - Global Industry Analysis, Size, Share,Growth, Trends and Forecast, 2013 - 2019 " to it's Large Report database.

This report includes market estimations for Nanomedicine Market for the forecast period 2013 - 2019. The market size is represented in terms of USD billion and the market estimates and forecasts are calculated, considering 2012 as the base year. Moreover, market trends and recent developments have been kept into account while forecasting market growth and revenue for the period 2013 - 2019.

The overall nanomedicine market is segmented on the basis of application and geography and the market estimations for each of these segments, in terms of USD billion, is provided in this report.

The nanomedicine market, by applications is segmented into neurological, cardiovascular, oncology, anti-inflammatory, anti-infective and other markets. The nanomedicine market is also estimated and analyzed on the basis of geographic regions such as North America, Europe, Asia-Pacific and rest of the world.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=184595

The global trends such as drivers, restraints and opportunities of the global nanomedicine market is detailed in the market overview chapter of this report., with a view on impact of these factors on market growth along the course of the forecast period.

The chapter on competitive landscape consists of heat map analysis of the key players operating in the global nanomedicine market. Some of the key players of this market include GE Healthcare, Mallinckrodt plc, Nanosphere Inc., Pfizer Inc., Merck & Co Inc., Celgene Corporation, CombiMatrix Corporation, Abbott Laboratories and others. The role of these market players in the global nanomedicine market is analyzed by profiling them on the basis of attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments.

Read All Medical Equipments Market Research Reports @ http://www.researchmoz.us/medical-equipments-market-reports-109.html

Table of Content

Chapter 1 Preface
1.1 Report description
1.2 Research Methodology
1.3 Market Segmentation

Chapter 2 Executive Summary

Chapter 3 Global Nanomedicine Market Overview
3.1 Market Dynamics
3.1.1 Market Drivers
3.1.1.1 Improvement in technology for nanomedicine
3.1.1.2 Rising government support for research and development in nanomedicine
3.1.1.3 Presence of high unmet medical needs
3.1.1.4 Increase in investment amount and healthcare collaborations
3.1.1.5 High prevalence of chronic diseases
3.1.1.6 Impact Analysis of the Market Drivers
3.1.2 Market Restraints
3.1.2.1 Lack of organized regulatory framework
3.1.2.2 High costs involved
3.1.2.3 Impact Analysis of the Market Restraints
3.1.3 Market Opportunities
3.1.3.1 Presence of unmet medical needs in emerging economies
3.1.3.2 Identification of new medical applications
3.2 Porter’s Five Forces Analysis: Global Nanomedicine Market
3.2.1 Bargaining Power of Suppliers
3.2.2 Bargaining Power of Buyers
3.2.3 Threat of New entrants
3.2.4 Threat of Substitutes
3.2.5 Competitive Rivalry

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

Monday 27 February 2017

Bordetella Pertussis Infections Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020

ResearchMoz added Latest Research Report titled " Bordetella Pertussis Infections Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast, 2014 - 2020 " to it's Large Report database.

Pertussis, commonly known as whooping cough is caused due to a coccobacillus, aerobic, non motile, gram-negative bacteria called Bordetella Pertussis. The virulence factors of B. pertussis include filamentous hemagglutinin, pertussis toxin, fimbria, pertactin and tracheal cytotoxin. These bacteria get transmitted to susceptible individuals from respiratory droplets of infected ones, as they mainly attack the mucosal layers of the respiratory tract. Pertussis can cause serious illnesses in children, newborns and even in adults, and can prove to be life threatening especially for newborns. Immunization programs against pertussis have been adopted in most of the countries of the world to protect their children against this disease. However, at present many pharmaceutical companies have also concentrated their efforts in developing therapeutic drugs for effective management of this disease.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=222479

Some of the major driving factors for the growth of this market include high prevalence of pertussis especially in low to medium income countries, high number of deaths among infants, increasing number of vaccination programs and rising demand for advanced therapeutics. According to the World Health Organization (WHO) estimates, around 16 million cases of pertussis were recorded worldwide in 2008, of which 95% cases were in developing nations. It was also estimated that it killed more than 195,000 children globally that year. Infant immunization programs that utilize different pertussis vaccines of listed quality have proven extremely successful in preventing pertussis in infants all over the world for several decades. However, according to Centers for Disease Control and Prevention (CDC), U.S., more than 48,000 cases of pertussis were reported only in the U.S. in 2012, where many cases also went undiagnosed and unreported. And, according to the CDC estimates it was concluded that this was the most number of pertussis cases that have been reported since 1995, when more than 62,000 pertussis cases were reported. Thus, rising awareness among people about the severity of the disease have caused increase in demand for advanced therapeutic drugs in the same category. Several pharmaceutical companies have range of molecules under clinical trials, which will soon be commercialized in the global market to give a boost to its future growth opportunities. Some of the molecules that are under different stages of clinical trials include, GSK2202083A + Prevenar 13 + Rotarix, V419 + Prevnar 13 + RotaTeq, TAK-361S, DtwP-HB-Hib and DTP-HepB-Polio-Hib among others.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Among all the regions, North America and Europe are expected to dominate the global Bordetella pertussis infections market owing to the factors such as high demand for advanced therapeutic drugs for treating newly born babies along with high awareness, acceptability and affordability of the people in these regions. However, Asia Pacific region is expected to exhibit a rapid growth in this market in future due to factors like high prevalence of pertussis in the region along with increasing healthcare awareness and purchasing power of the population. Most of the emerging economies of the world are located in this region and more than 95% cases of pertussis that have been reported globally are accounted by the developing regions of the world. Hence, the region is bound to show a rapid growth in future. Various pharmaceutical manufacturers are engaged in the development of therapeutic drugs and vaccines for effective management of pertussis globally.

Some of the major players having their molecules in different stages of clinical trials are GlaxoSmithKline plc, LG Life Sciences, Ltd., Merck & Co., Inc., Novartis Vaccines and Diagnostics, Inc. (Novartis AG), Panacea Biotec Limited, Sanofi and Takeda Pharmaceutical Company Limited.

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include
  •     North America
  •     Asia Pacific
  •     Europe
  •     Rest of the World 
This report provides comprehensive analysis of
  •     Market growth drivers
  •     Factors limiting market growth
  •     Current market trends
  •     Market structure
  •     Market projections for upcoming years
About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG

External Defibrillator Market in India 2014 Industry is Exhibiting Steady Growth and Promises Ample Opportunities

ResearchMoz added Latest Research Report titled " External Defibrillator Market in India 2014 " to it's Large Report database.

Netscribes latest market research report titled External Defibrillator Market in India 2014 states that the demand for external defibrillators is rising in the country due to a number of reasons. Cardiovascular and other lifestyle diseases plaguing a large number of Indians has resulted in a strong case for the growth of healthcare institutions. The number of hospitals and emergency and trauma care centers being set up in the country has been increasing and this in turn is leading to a rise in the demand for defibrillators as these equipments are indispensable to any healthcare institution. Biphasic defibrillators are replacing the monophasic models in most centers and is hence growing at the cost of the latter. However, monophasic defibrillators are still experiencing some demand, especially in rural settings.

Request for Sample PDF of Premium Research Report with TOC: http://www.researchmoz.us/enquiry.php?type=S&repid=222651

On the other hand, the portability of automated external defibrillators along with its increased usage in public places such as railway stations, airports, shopping malls, etc. has ensured that this segment is exhibiting the highest growth.

There is an equal mix of domestic and foreign companies operating in the market and high competitive rivalry exist between them. While Indian companies try to provide no-frills products, foreign firms try to provide additional features in their products. As a result products of foreign companies are priced slightly higher than the products of Indian companies and these products are mostly used by top-end hospitals in tier I cities. However, the expansion of medical centers providing quality care in smaller cities and towns, is helping the Indian companies to grow as well. Overall, the market is exhibiting steady growth and promises ample opportunities to all the players operating in the market.

Read All Healthcare Market Research Reports @ http://www.researchmoz.us/healthcare-market-reports-56.html

Table of Content

Slide 1: Executive Summary

Macroeconomic Indicators
Slide 2: GDP at Factor Cost: Quarterly (2010-11, 2011-12, 2012-13, 2013-14), Inflation Rate: Monthly (Jul 2013 Dec 2013)
Slide 3: Gross Fiscal Deficit: Monthly (Feb 2013 Jul 2013), Exchange Rate: Half Yearly (Oct 2013 Mar 2014)
Slide 4: Lending Rate: Annual (2008-09, 2009-10, 2010-11, 2011-12), Trade Balance: Annual (2010-11, 2011-12, 2012-13, 2013-14), FDI: Annual (2009-10, 2010-11, 2011-12, 2012-13)

Introduction
Slide 5: Types of External Defibrillators
Slide 6: Biphasic Defibrillators Versus Monophasic Defibrillators

Market Overview
Slide 7: External Defibrillators Market Overview, Market Size & Growth (Volume-Wise; 2012 2018e & Value-Wise; 2012 2018e)
Slide 8: Monophasic Defibrillators Market Overview, Market Size & Growth (Volume-Wise; 2012 2018e & Value-Wise; 2012 2018e)
Slide 9: Biphasic Defibrillators Market Overview, Market Size & Growth (Volume-Wise; 2012 2018e & Value-Wise; 2012 2018e)
Slide 10: Automated External Defibrillators Market Overview, Market Size & Growth (Volume-Wise; 2013 2018e & Value-Wise; 2013e 2018e)

EXIM
Slide 11: Export of Defibrillators Overview, Size (Value-Wise & Volume-Wise: 2010-11 2013-14), Region-Wise Exports (Value-Wise: 2012-13, 2013-14)
Slide 12: Import of Defibrillators Overview, Size (Value-Wise & Volume-Wise: 2010-11 2013-14), Region-Wise Imports (Value-Wise; 2012-13, 2013-14)

About ResearchMoz

ResearchMoz is the world's fastest growing collection of market research reports worldwide. Our database is composed of current market studies from over 100 featured publishers worldwide. Our market research databases integrate statistics with analysis from global, regional, country and company perspectives. ResearchMoz's service portfolio also includes value-added services such as market research customization, competitive landscaping, and in-depth surveys, delivered by a team of experienced Research Coordinators.

Contact Us:

Mr. Nachiket Ghumare
90 State Street, Albany NY, United States - 12207
Tel: +1-518-621-2074 / Tel: 866-997-4948 (Us-Canada Toll Free)
Email: sales@researchmoz.us
Follow us on LinkedIn at: http://bit.ly/1TBmnVG